BRENTWOOD, Tenn., April 16, 2019 /PRNewswire/ -- AAC Holdings, Inc.
(NYSE: AAC) ("the Company") announced financial results for the
fourth quarter and year ended December 31,
2018, as well as 2019 guidance.
Fourth Quarter 2018 Operational and Financial
Highlights:
(All comparisons are to the comparable
prior-year period, unless otherwise noted)
- Total inpatient daily census improved by 26% at March 31, 2019 compared to December 31, 2018
- Total revenue decreased 26.6% to $57.4
million on a comparable accounting basis (total revenue
decreased 33.3% on an as reported basis)
- Net loss attributable to AAC Holdings, Inc. common stockholders
was $36.7 million, or $(1.52) per diluted common share
- Adjusted EBITDA was $(12.4)
million (see non-GAAP reconciliation herein)
- Adjusted loss per diluted common share was $(0.85) (see non-GAAP reconciliation herein)
- New admissions increased 39% to 4,184 a (increase related to
the acquisition of AdCare on March 1,
2018)
- Total average daily census (ADC) was 1,002 compared to 995
(increase related to the acquisition of AdCare on March 1, 2018)
- Outpatient visits increased 104% to 44,165 (increase primarily
related to the acquisition of AdCare on March 1, 2018)
- Implemented over $30 million in
annualized expense reductions to benefit 2019 operating
margins
- Closed a $30 million incremental
term loan with existing lenders to provide additional
liquidity
"The last several months of 2018 saw a census decline that was
more significant than we originally anticipated, with an initial
30% drop in call volume resulting in a sharp decrease in admissions
in the second half of 2018 which resulted in a corresponding
decrease in revenue," said Michael
Cartwright, Chairman and Chief Executive Officer of AAC
Holdings, Inc. "However, admissions have begun to improve in early
2019, with average admissions per day up by more than 25% for
March 2019 compared to December 2018. The initiatives in sales and
marketing we launched last year and continue to implement into 2019
are showing results and we continue to enhance our online outreach
resources to better help those who need our help."
"We also acted quickly to improve liquidity and reduce operating
expenses. We recently announced the closing of a $30 million incremental term loan that provides
us with additional liquidity moving into 2019. We have also
commenced a process to explore ways to generate additional value
from our attractive treatment center real estate portfolio in order
to improve our balance sheet. Finally, we continue to be focused on
cost reduction initiatives. The expense savings initiatives
implemented in late 2018 and in the first quarter of 2019, are
expected to total over $30 million in
annualized savings."
"Despite the challenges we faced last year, we've started this
year with positive momentum and I'm confident that we will see
continued improvement throughout 2019. We believe we have the right
things to help us get there – significant cost savings initiatives,
options with our real estate portfolio, new processes in place
within our sales and marketing team, and most of all our continued
commitment to excellent clinical care."
Evaluation of Strategic Alternatives in AAC's Real Estate
Portfolio
The Company has commenced a process to explore strategic
alternatives to generate additional value from its real estate
portfolio consisting of treatment centers located across
the United States. Management's
goal is to leverage the portfolio to create additional liquidity,
lower its cost of capital and enhance shareholder value. Real
estate strategic alternatives could include further sale leasebacks
of individual facilities or larger portions of the Company's real
estate portfolio.
Cost Savings Initiatives
The Company enacted a series of cost savings initiatives during
the fourth quarter for 2018 and into the first quarter of 2019
which are expected to result in over $30
million of annualized cost savings. These initiatives have
included reductions in the Company's corporate expenses,
consolidation of its Las Vegas
market, consolidation of the its southern California market, the sale of the Company's
New Orleans operations, and the
consolidation of its lab operations.
Incremental Term Loan and Amendment of Existing Credit
Facility
In March 2019, the Company closed
a $30 million incremental term loan
with its existing lenders. In addition, the Company amended its
existing secured credit facility to, among other items, provide
increased flexibility with respect to certain financial
covenants.
Restatement
On March 29, 2019, the Company,
the Audit Committee of the Company's Board of Directors and
executive management, in consultation with the Company's
independent registered public accounting firm, BDO USA, LLP ("BDO"), determined that adjustments
to certain of its previously issued annual and interim financial
statements were necessary, and that those annual and interim
financial statements could no longer be relied upon. The
adjustments related to estimates of accounts receivable, provision
for doubtful accounts and revenue for the relevant periods
described below, as well as the related income tax effects. Certain
other immaterial reclassifications within the financial statements
are also reflected in the adjustments. The restatements do not
implicate misconduct with respect to the Company, its management or
its employees.
The Company's previously issued annual financial statements are
included in the Company's Annual Report on Form 10-K for the years
ended December 31, 2017 and 2016 and
the unaudited financial statements and included in the Company's
quarterly reports on Form 10-Q for the quarters ended September 30, 2018 and 2017, June 30, 2018 and 2017, and March 31, 2018 and 2017, have been restated in
the Company's 2018 Annual Report on Form 10-K for the year ended
December 31, 2018 to properly reflect
these corrections.
The adjustments do not relate to the change in estimate that the
Company made during the three months ended September 30, 2018 and effective as of
July 1, 2018, regarding its estimate
of the collectability of accounts receivable, specifically relating
to accounts where the Company has received a partial payment from a
commercial insurance company, and the Company continues to pursue
additional collections for the balance that it estimates remains
outstanding or "partial payment accounts receivable".
All comparisons to prior period results contained in this
release are presented on an as restated basis.
Adoption of New Revenue Recognition Standard
In May 2014, the FASB issued
Accounting Standards Codification Topic 606, "Revenue from
Contracts with Customers" (ASC Topic 606), a replacement of Revenue
Recognition ASC Topic 605. The Company adopted ASC Topic 606 on
January 1, 2018 using the modified
retrospective approach. Under ASC Topic 606, the provision for
doubtful accounts, which historically was reported as an operating
expense, is now reported as a direct reduction to revenue effective
January 1, 2018. This change in
presentation reduced revenues and operating expenses by the same
amount and did not have an effect on net income or earnings per
share. As the Company adopted ASC Topic 606 using the modified
retrospective approach, prior year periods were not recast and as
such, revenues as reported for those periods are not comparable to
the current year presentation. For purposes of this release, the
Company has applied its adoption of ASC Topic 606 to the prior year
period. The Company believes this allows for an accurate comparison
of prior period revenue. Where the Company has used language such
as "less the provision for doubtful accounts" or "on a comparable
accounting basis," this indicates a comparison of periods that
reflects the Company's adoption of ASC Topic 606.
AdCare Acquisition
On March 1, 2018, AAC acquired
AdCare, Inc. and its subsidiaries ("AdCare"). AdCare offers
treatment for drug and alcohol addiction and includes, among other
things, a 114-bed hospital and 5 outpatient centers in
Massachusetts, as well as
a 59-bed residential inpatient treatment center and 2
outpatient centers in Rhode
Island. AdCare was purchased for total consideration of
$85.0 million, subject to
adjustments.
Fourth Quarter 2018 Financial Results
AAC breaks down its revenues between client related revenue and
non-client related revenue. Client related revenue includes: (1)
inpatient treatment facility services and related professional
services; (2) outpatient facility services, related professional
services and sober living services; and (3) client related
diagnostic services, which includes point of care drug testing and
client related diagnostic laboratory services. Non-client related
revenue includes marketing and diagnostic services provided to
third parties as well as addiction services provided to individuals
in the criminal justice system.
Total revenue on a comparable accounting basis (i.e., less the
provision for doubtful accounts) decreased 26.6% to $57.4 million compared with $78.3 million in the same period in the prior
year. Total revenue on an as reported decreased 33.3%, to
$57.4 million compared with
$86.1 million in the same period in
the prior year.
|
2018
|
|
|
2017
(Comparable
Basis)
|
|
|
Increase
(Decrease)
|
|
|
%
Change
|
|
Inpatient treatment
facility services
|
$
|
47,132
|
|
|
$
|
66,822
|
|
|
$
|
(19,690)
|
|
|
|
(29.5)
|
|
Outpatient facility
and sober living
services
|
|
5,631
|
|
|
|
8,654
|
|
|
|
(3,023)
|
|
|
|
(34.9)
|
|
Client related
diagnostic services
|
|
2,405
|
|
|
|
340
|
|
|
|
2,065
|
|
|
|
607.4
|
|
Total client related
revenue
|
|
55,168
|
|
|
|
75,816
|
|
|
|
(20,648)
|
|
|
|
(27.2)
|
|
Non-client related
revenue
|
|
2,280
|
|
|
|
2,457
|
|
|
|
(177)
|
|
|
|
(7.2)
|
|
Total client related
revenue
|
$
|
57,448
|
|
|
$
|
78,273
|
|
|
$
|
(20,825)
|
|
|
|
(26.6)
|
|
Inpatient treatment facility revenue, on a comparable accounting
basis, decreased 29.5% to $47.1
million compared with $66.8
million in the same period in the prior year. ADR decreased
31.1% to $688 compared with
$999 in the same period in the prior
year.
Outpatient and sober living facility revenue, on a comparable
accounting basis, decreased 34.9% to $5.6
million compared with $8.7
million in the same period in the prior year. Average
revenue per outpatient visit (ARV) decreased 69.6% to $127 compared with $418 in the same period in the prior year.
Client related diagnostic services revenue, on a comparable
accounting basis, increased 607.4% to $2.4
million compared with $0.3
million in the same period in the prior year.
Non-client related revenue, on a comparable accounting
basis, decreased 7.2% to $2.3 million
compared with $2.5 million in the
same period in the prior year.
Net loss attributable to AAC Holdings, Inc. common stockholders
was $36.7 million, or $(1.52) per diluted common share, compared with
$16.1 million, or $(0.69) per diluted common share, in the
prior-year period.
Adjusted EBITDA decreased to $(12.4)
million compared with $18.3
million for the same period in the prior year. Adjusted net
loss attributable to AAC Holdings, Inc. common stockholders
decreased to $20.7 million, or
$(0.85) per diluted common share,
compared with adjusted net income of $9.4
million, or $0.40 per diluted
common share, for the same period in the prior year. Adjusted
EBITDA, adjusted net income attributable to AAC Holdings, Inc.
common stockholders and adjusted earnings per diluted common share
are non-GAAP financial measures. Tables reconciling these non-GAAP
measures to the most directly comparable GAAP measures are included
at the end of this release.
Full Year 2018 Financial Results
Total revenue on a comparable accounting basis (i.e., less the
provision for doubtful accounts) increased 1.4% to $295.8 million compared with $291.7 million in the same period in the prior
year. Total revenue as reported decreased 6.9% to $295.8 million compared with $317.6 million in the prior year.
|
2018
|
|
|
2017
(Comparable
Basis)
|
|
|
Increase
(Decrease)
|
|
|
%
Change
|
|
|
Amount
|
|
|
Amount
|
|
|
Amount
|
|
|
%
|
|
Inpatient treatment
facility services
|
$
|
235,513
|
|
|
$
|
230,461
|
|
|
$
|
5,052
|
|
|
|
2.2
|
|
Outpatient facility
and sober living
services
|
|
34,405
|
|
|
|
28,710
|
|
|
|
5,695
|
|
|
|
19.8
|
|
Client related
diagnostic services
|
|
14,607
|
|
|
|
23,435
|
|
|
|
(8,828)
|
|
|
|
(37.7)
|
|
Total client related
revenue
|
|
284,525
|
|
|
|
282,606
|
|
|
|
1,919
|
|
|
|
0.7
|
|
Non-client related
revenue
|
|
11,238
|
|
|
|
9,103
|
|
|
|
2,135
|
|
|
|
23.5
|
|
Total client related
revenue
|
$
|
295,763
|
|
|
$
|
291,709
|
|
|
$
|
4,054
|
|
|
|
1.4
|
|
Inpatient treatment facility revenue, on a comparable accounting
basis, increased 2.2% to $235.5
million compared with $230.5
million in the same period in the prior year. ADR decreased
2.2% to $800 compared with
$818 in the same period in the prior
year.
Outpatient and sober living facility revenue, on a comparable
accounting basis, increased 19.8% to $34.4
million compared with $28.7
million in the same period in the prior year. ARV decreased
50.9% to $198 compared with
$403 in the same period in the prior
year.
Client related diagnostic services revenue, on a comparable
accounting basis, decreased 37.7% to $14.6 million compared with $23.4 million in the same period in the prior
year.
Non-client related revenue, on a comparable accounting
basis, increased 23.5% to $11.2
million compared with $9.1
million in the same period in the prior year.
Net loss attributable to AAC Holdings, Inc. common stockholders
was $59.4 million, or $(2.47) per diluted common share, compared with
$12.9 million, or $(0.55) per diluted common share, in the
prior-year period.
Adjusted EBITDA decreased 65.1% to $23.7
million compared with $67.9
million for the same period in the prior year. Adjusted net
loss attributable to AAC Holdings, Inc. common stockholders
decreased to $25.6 million, or
$(1.06) per diluted common share,
compared with adjusted net income of $27.0
million, or $1.16 per diluted
common share, for the same period in the prior year. Adjusted
EBITDA, adjusted net income attributable to AAC Holdings, Inc.
common stockholders and adjusted earnings per diluted common share
are non-GAAP financial measures. Tables reconciling these non-GAAP
measures to the most directly comparable GAAP measures are included
at the end of this release.
Balance Sheet and Cash Flows
As of December 31, 2018, AAC
Holdings' balance sheet reflected cash and cash equivalents of
$5.4 million, net property and
equipment of $166.9 million and total
debt of $319.2 million (current and
long-term portions). In March 2019,
we closed on a $30 million
incremental term loan that provides the company with additional
liquidity moving into 2019.
Cash flows used in operations totaled $9.1 million and maintenance capital expenditures
totaled $0.6 million for the fourth
quarter of 2018.
2019
Outlook
|
|
AAC announces its
guidance for the full year 2019 as follows:
|
|
|
|
Full Year 2019
Guidance
|
|
|
(in millions,
except share
data)
|
Total
Revenues
|
|
$290 -
$310
|
Inpatient treatment
facility revenue
|
|
$240 -
$245
|
Outpatient and
sober living facility revenue
|
|
$30 -
$35
|
Client related
diagnostic services revenue
|
|
$10 -
$15
|
Non-client related
revenue
|
|
$10 -
$15
|
|
|
|
Adjusted
EBITDA
|
|
$45 -
$55
|
Adjusted Earnings per
Diluted Common Share
|
|
$(0.30) -
$(0.20)
|
The Company expects diluted weighted-average common shares
outstanding of approximately 25.0 million for the year.
The outlook above does not include the impact of any future
acquisitions, transaction-related costs, litigation settlement or
expenses related to legal defenses.
With respect to the "2019 Outlook" above, reconciliation of
adjusted EBITDA and adjusted earnings per diluted common share
guidance to the closest corresponding GAAP measure on a
forward-looking basis is not available without unreasonable
efforts. This inability results from the inherent difficulty in
forecasting generally and quantifying certain projected amounts
that are necessary for such reconciliations. In particular,
sufficient information is not available to calculate certain
adjustments required for such reconciliations, including de novo
start-up and other expense and acquisition-related expenses. We
expect these adjustments may have a potentially significant impact
on future GAAP financial results.
Earnings Conference Call
The Company will host a conference call and live audio webcast
on Tuesday, April 16, 2019, at
9:00 a.m. CT to further discuss these
results. The number to call for this interactive teleconference is
1-877-224-7960. A replay of the conference call will be available
through April 30, 2019, by dialing
877-344-7529 and entering the replay access code, 10128808.
The live audio webcast of the Company's quarterly conference
call will also be available online in the Investor Relations
section of the Company's website at
ir.americanaddictioncenters.org.
About American Addiction Centers
American Addiction Centers is a leading provider of inpatient
and outpatient substance abuse treatment services. We treat clients
who are struggling with drug addiction, alcohol addiction and
co-occurring mental/behavioral health issues. We currently operate
substance abuse treatment facilities located throughout
the United States. These
facilities are focused on delivering effective clinical care and
treatment solutions. For more information, please find us at
AmericanAddictionCenters.org or follow us on Twitter.
Forward Looking Statements
This Annual Report on Form 10-K contains forward-looking
statements within the meaning of the federal securities laws. These
forward-looking statements are made only as of the date of this
Annual Report. In some cases, you can identify forward-looking
statements by terms such as "anticipates," "believes," "could,"
"estimates," "expects," "may," "potential," "predicts," "projects,"
"should," "will," "would," and similar expressions intended to
identify forward-looking statements, although not all
forward-looking statements contain these words. Forward-looking
statements may include information concerning the Company's
possible or assumed future results of operations, including
descriptions of the Company's revenue, profitability, outlook and
overall business strategy. These statements involve known and
unknown risks, uncertainties and other factors that may cause our
actual results and performance to be materially different from the
information contained in the forward-looking statements. These
risks, uncertainties and other factors include, without limitation:
(i) our inability to effectively operate our facilities; (ii) our
reliance on our sales and marketing program to continuously attract
and enroll clients; (iii) a reduction in reimbursement rates by
certain third-party payors for inpatient and outpatient services
and point-of-care and definitive lab testing; (iv) our failure to
successfully achieve growth through acquisitions and de novo
projects; (v) risks associated with estimates of the value of
accounts receivable or deterioration in collectability of accounts
receivable; (vi) a failure to achieve anticipated financial results
from contemplated and prior acquisitions; (vii) the possibility
that a governmental entity may prohibit, delay or refuse to grant
approval for the consummation of an acquisition; (viii) our failure
to achieve anticipated financial results from contemplated and
prior acquisitions; (ix) a disruption in our ability to perform
diagnostic laboratory services; (x) maintaining compliance with
applicable regulatory authorities, licensure and permits to operate
our facilities and laboratories; (xi) a disruption in our business
and reputational and economic risks associated with the civil
securities claims brought by shareholders or claims by various
parties; (xii) inability to meet the covenants in our loan
documents or lack of borrowing capacity; and (xiii) general
economic conditions, as well as other risks discussed in the "Risk
Factors" section of our Annual Report on Form 10-K and our other
filings with the Securities and Exchange Commission. As a result of
these factors, we cannot assure that the forward-looking statements
in our annual report will prove to be accurate. Investors should
not place undue reliance upon forward-looking statements.
AAC HOLDINGS,
INC.
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
Unaudited
|
|
(Dollars in
thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
Years Ended
December 31,
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Client related
revenue
|
$
|
55,168
|
|
|
$
|
83,679
|
|
|
$
|
284,525
|
|
|
$
|
308,538
|
|
Non-client related
revenue
|
|
2,280
|
|
|
|
2,457
|
|
|
|
11,238
|
|
|
|
9,103
|
|
Total
revenues
|
|
57,448
|
|
|
|
86,136
|
|
|
|
295,763
|
|
|
|
317,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, wages and
benefits
|
|
43,007
|
|
|
|
38,401
|
|
|
|
174,772
|
|
|
|
146,390
|
|
Client related
services
|
|
8,013
|
|
|
|
7,409
|
|
|
|
32,747
|
|
|
|
27,031
|
|
Provision for doubtful
accounts
|
|
—
|
|
|
|
7,862
|
|
|
|
366
|
|
|
|
25,932
|
|
Advertising and
marketing
|
|
5,524
|
|
|
|
2,200
|
|
|
|
13,744
|
|
|
|
12,315
|
|
Professional
fees
|
|
5,597
|
|
|
|
3,316
|
|
|
|
19,894
|
|
|
|
12,638
|
|
Other operating
expenses
|
|
12,101
|
|
|
|
11,015
|
|
|
|
47,716
|
|
|
|
36,309
|
|
Rentals and
leases
|
|
2,928
|
|
|
|
1,675
|
|
|
|
10,367
|
|
|
|
7,514
|
|
Litigation
settlement
|
|
8,001
|
|
|
|
23,607
|
|
|
|
11,136
|
|
|
|
23,607
|
|
Depreciation and
amortization
|
|
5,040
|
|
|
|
5,759
|
|
|
|
21,986
|
|
|
|
21,504
|
|
Acquisition-related
expenses
|
|
(19)
|
|
|
|
567
|
|
|
|
573
|
|
|
|
1,162
|
|
Total operating
expenses
|
|
90,192
|
|
|
|
101,811
|
|
|
|
333,301
|
|
|
|
314,402
|
|
Loss from
operations
|
|
(32,744)
|
|
|
|
(15,675)
|
|
|
|
(37,538)
|
|
|
|
3,239
|
|
Interest expense,
net
|
|
8,880
|
|
|
|
5,739
|
|
|
|
32,220
|
|
|
|
16,811
|
|
Gain on contingent
consideration
|
|
(1,272)
|
|
|
|
—
|
|
|
|
(501)
|
|
|
|
—
|
|
Loss on
extinguishment of debt
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
5,435
|
|
Other expense,
net
|
|
(178)
|
|
|
|
39
|
|
|
|
465
|
|
|
|
116
|
|
Loss before income
tax benefit
|
|
(40,174)
|
|
|
|
(21,453)
|
|
|
|
(69,722)
|
|
|
|
(19,123)
|
|
Income tax
benefit
|
|
(1,729)
|
|
|
|
(3,965)
|
|
|
|
(3,004)
|
|
|
|
(1,742)
|
|
Net loss
|
|
(38,445)
|
|
|
|
(17,488)
|
|
|
|
(66,718)
|
|
|
|
(17,381)
|
|
Less: net loss
attributable to noncontrolling
interest
|
|
1,768
|
|
|
|
1,359
|
|
|
|
7,314
|
|
|
|
4,508
|
|
Net loss attributable
to AAC Holdings, Inc.
common
stockholders
|
$
|
(36,677)
|
|
|
$
|
(16,129)
|
|
|
$
|
(59,404)
|
|
|
$
|
(12,873)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per common
share
|
$
|
(1.51)
|
|
|
$
|
(0.69)
|
|
|
$
|
(2.47)
|
|
|
$
|
(0.55)
|
|
Diluted loss per
common share
|
$
|
(1.51)
|
|
|
$
|
(0.69)
|
|
|
$
|
(2.47)
|
|
|
$
|
(0.55)
|
|
Weighted-average
common shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
24,242,663
|
|
|
|
23,396,502
|
|
|
|
24,090,639
|
|
|
|
23,277,444
|
|
Diluted
|
|
24,242,663
|
|
|
|
23,396,502
|
|
|
|
24,090,639
|
|
|
|
23,277,444
|
|
AAC HOLDINGS,
INC.
|
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|
(Dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December
31,
|
|
|
December
31,
|
|
|
|
2018
|
|
|
2017
|
|
Assets
|
|
|
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
5,409
|
|
|
$
|
13,818
|
|
Accounts receivable,
net of allowances
|
|
|
47,860
|
|
|
|
63,746
|
|
Prepaid expenses and
other current assets
|
|
|
10,695
|
|
|
|
4,022
|
|
Total current
assets
|
|
|
63,964
|
|
|
|
81,586
|
|
Property and
equipment, net
|
|
|
166,921
|
|
|
|
152,548
|
|
Goodwill
|
|
|
198,952
|
|
|
|
134,396
|
|
Intangible assets,
net
|
|
|
12,063
|
|
|
|
8,829
|
|
Deferred tax assets,
net
|
|
|
-
|
|
|
|
1,650
|
|
Other
assets
|
|
|
10,377
|
|
|
|
12,556
|
|
Total
assets
|
|
$
|
452,277
|
|
|
$
|
391,565
|
|
|
|
|
|
|
|
|
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
13,507
|
|
|
$
|
4,579
|
|
Accrued and other
current liabilities
|
|
|
30,544
|
|
|
|
27,661
|
|
Accrued
litigation
|
|
|
8,000
|
|
|
|
23,607
|
|
Current portion of
long-term debt
|
|
|
309,394
|
|
|
|
4,722
|
|
Total current
liabilities
|
|
|
361,445
|
|
|
|
60,569
|
|
Deferred tax
liabilities, net
|
|
|
1,227
|
|
|
|
-
|
|
Long-term debt, net
of current portion and debt issuance costs
|
|
|
9,764
|
|
|
|
196,451
|
|
Financing lease
obligation, net of current portion
|
|
|
24,421
|
|
|
|
24,541
|
|
Other long-term
liabilities
|
|
|
13,147
|
|
|
|
10,546
|
|
Total
liabilities
|
|
|
410,004
|
|
|
|
292,107
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity
|
|
|
64,413
|
|
|
|
114,284
|
|
Noncontrolling
interest
|
|
|
(22,140)
|
|
|
|
(14,826)
|
|
Total
stockholders' equity including noncontrolling
interest
|
|
|
42,273
|
|
|
|
99,458
|
|
Total liabilities
and stockholders' equity
|
|
$
|
452,277
|
|
|
$
|
391,565
|
|
AAC HOLDINGS,
INC.
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
(Dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended
December 31,
|
|
|
2018
|
|
|
2017
|
|
Cash flows (used
in) provided by operating activities:
|
|
|
|
|
|
|
|
Net loss
|
$
|
(66,718)
|
|
|
$
|
(17,381)
|
|
Adjustments to
reconcile net loss to net cash (used in) provided
by operating
activities:
|
|
|
|
|
|
|
|
Provision for doubtful
accounts
|
|
366
|
|
|
|
25,932
|
|
Depreciation and
amortization
|
|
21,986
|
|
|
|
21,504
|
|
Equity
compensation
|
|
3,877
|
|
|
|
7,513
|
|
Loss on extinguishment
of debt
|
|
1,007
|
|
|
|
55
|
|
Loss on impairment of
goodwill
|
|
—
|
|
|
|
5,435
|
|
Loss on disposal of
property and equipment
|
|
(501)
|
|
|
|
—
|
|
Amortization of debt
issuance costs
|
|
2,797
|
|
|
|
1,564
|
|
Deferred income
taxes
|
|
2,878
|
|
|
|
(4,136)
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
19,876
|
|
|
|
(43,676)
|
|
Prepaid expenses and
other assets
|
|
(5,578)
|
|
|
|
(6,725)
|
|
Accounts
payable
|
|
5,737
|
|
|
|
(4,576)
|
|
Accrued and other
current liabilities
|
|
1,780
|
|
|
|
4,685
|
|
Accrued
litigation
|
|
(15,607)
|
|
|
|
22,645
|
|
Other long-term
liabilities
|
|
(754)
|
|
|
|
6,453
|
|
Net cash (used in)
provided by operating activities
|
|
(28,854)
|
|
|
|
19,292
|
|
Cash flows used in
investing activities:
|
|
|
|
|
|
|
|
Purchase of property
and equipment
|
|
(18,949)
|
|
|
|
(33,041)
|
|
Acquisition of
subsidiaries
|
|
(65,827)
|
|
|
|
—
|
|
Change in funds held
on acquisition
|
|
—
|
|
|
|
(1,000)
|
|
Net cash used in
investing activities
|
|
(84,776)
|
|
|
|
(34,041)
|
|
Cash flows
provided by financing activities:
|
|
|
|
|
|
|
|
Payments on 2015
Credit Facility and Deerfield Facility
|
|
—
|
|
|
|
(211,094)
|
|
Proceeds from 2015
Credit Facility and Deerfield Facility, net of deferred financing costs
|
|
—
|
|
|
|
18,000
|
|
Payments on 2017
Credit Facility
|
|
(6,896)
|
|
|
|
(17,126)
|
|
Proceeds from 2017
Credit Facility, net of deferred financing costs
|
|
114,286
|
|
|
|
211,073
|
|
Proceeds from
financing lease obligation, net of deferred financing
costs
|
|
—
|
|
|
|
24,621
|
|
Payments on capital
leases and other
|
|
(798)
|
|
|
|
(791)
|
|
Payments on AdCare
Note
|
|
(750)
|
|
|
|
—
|
|
Change in funds held
on acquisition
|
|
—
|
|
|
|
1,000
|
|
Payment of employee
taxes for net share settlement
|
|
(621)
|
|
|
|
(1,080)
|
|
Net cash provided by
financing activities
|
|
105,221
|
|
|
|
24,603
|
|
Net change in cash
and cash equivalents
|
|
(8,409)
|
|
|
|
9,854
|
|
Cash and cash
equivalents, beginning of period
|
|
13,818
|
|
|
|
3,964
|
|
Cash and cash
equivalents, end of period
|
$
|
5,409
|
|
|
$
|
13,818
|
|
AAC HOLDINGS,
INC.
|
|
OPERATING
METRICS
|
|
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
Years Ended
December 31,
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Operating
Metrics:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New
admissions1
|
|
4,184
|
|
|
|
3,018
|
|
|
|
18,099
|
|
|
|
12,299
|
|
Average daily
inpatient census2
|
|
745
|
|
|
|
737
|
|
|
|
807
|
|
|
|
775
|
|
Average daily sober
living census3
|
|
257
|
|
|
|
258
|
|
|
|
273
|
|
|
|
197
|
|
Total average daily
census
|
|
1,002
|
|
|
|
995
|
|
|
|
1,080
|
|
|
|
972
|
|
Average episode
length (days)4
|
|
22
|
|
|
|
28
|
|
|
|
22
|
|
|
|
28
|
|
Average daily
inpatient revenue5
|
$
|
688
|
|
|
$
|
999
|
|
|
$
|
800
|
|
|
$
|
818
|
|
Revenue per
admission6
|
$
|
13,185
|
|
|
$
|
27,727
|
|
|
$
|
15,720
|
|
|
$
|
25,086
|
|
Outpatient
visits7
|
|
44,165
|
|
|
|
21,651
|
|
|
|
174,123
|
|
|
|
72,155
|
|
Revenue per
outpatient visit8
|
$
|
127
|
|
|
$
|
418
|
|
|
$
|
198
|
|
|
$
|
403
|
|
Client related
diagnostic services9
|
|
5
|
%
|
|
|
4
|
%
|
|
|
5
|
%
|
|
|
11
|
%
|
Inpatient bed count
at end of period10
|
|
1,080
|
|
|
|
939
|
|
|
|
1,080
|
|
|
|
939
|
|
Effective inpatient
bed count at end of period11
|
|
1,076
|
|
|
|
939
|
|
|
|
1,076
|
|
|
|
939
|
|
Average effective
inpatient bed utilization12
|
|
69
|
%
|
|
|
78
|
%
|
|
|
73
|
%
|
|
|
78
|
%
|
Days sales
outstanding13
|
|
77
|
|
|
|
68
|
|
|
|
59
|
|
|
|
73
|
|
|
1
Represents total client admissions at our inpatient facilities for
the periods presented.
|
2
Represents average daily client census at all of our inpatient
facilities.
|
3
Represents average daily client census at our sober living
facilities.
|
4
Average episode length is the consecutive number of days from
admission to discharge that a client stays at an AAC
inpatient facility and, when applicable, an AAC sober
living facility.
|
5
Average daily inpatient revenue is calculated as total revenues
from all of our inpatient facilities less provision for doubtful
accounts during the period, divided by the product of the number of
days in the period multiplied by average daily inpatient
census.
|
6
Revenue per admission is calculated by dividing total client
related revenue, after the provision for doubtful accounts, by new
admissions.
|
7
Represents the total number of outpatient visits at our standalone
outpatient centers during the periods presented.
|
8
Revenue per outpatient visit is calculated as total revenues from
all of our standalone outpatient facilities, after the provision
for doubtful accounts, divided by the number of outpatient visits
during the period.
|
9
Client related diagnostic services revenue, as a percentage of
client related revenue, includes point-of-care and client related
diagnostic laboratory services.
|
10
Inpatient bed count at end of period includes all beds at inpatient
facilities.
|
11
Effective bed count at end of period represents the number of beds
for which our facilities are staffed based on planned
census.
|
12
Average effective inpatient bed utilization represents average
daily inpatient census divided by the average effective inpatient
bed count during the applicable period.
|
13
Days sales outstanding is calculated as accounts receivable,
net of allowance for doubtful accounts, at the end of the period
divided by revenues per day. Revenues per day is calculated by
dividing revenues for the period by the number of days in the
period.
|
|
AAC HOLDINGS,
INC.
|
|
SUPPLEMENTAL
RECONCILIATION OF NON-GAAP DISCLOSURES
|
|
Unaudited
|
|
(Dollars in
thousands)
|
|
Reconciliation of
Adjusted EBITDA to Net Loss (Income) Attributable to AAC Holdings,
Inc. Common
Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
Years Ended
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Net (loss) income
attributable to AAC Holdings,
Inc. common stockholders
|
|
$
|
(36,677)
|
|
|
$
|
(16,129)
|
|
|
$
|
(59,404)
|
|
|
$
|
(12,873)
|
|
Non-GAAP
Adjustments1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
8,880
|
|
|
|
5,739
|
|
|
|
32,220
|
|
|
|
16,811
|
|
Depreciation and
amortization
|
|
|
5,040
|
|
|
|
5,759
|
|
|
|
21,986
|
|
|
|
21,504
|
|
Income tax
benefit
|
|
|
(1,729)
|
|
|
|
(3,965)
|
|
|
|
(3,004)
|
|
|
|
(1,742)
|
|
Net loss attributable
to noncontrolling interest
|
|
|
(1,768)
|
|
|
|
(1,359)
|
|
|
|
(7,314)
|
|
|
|
(4,508)
|
|
Stock-based
compensation
|
|
|
773
|
|
|
|
1,465
|
|
|
|
3,877
|
|
|
|
7,513
|
|
Litigation settlement,
regulatory and California
matter related expense
|
|
|
8,611
|
|
|
|
24,028
|
|
|
|
15,531
|
|
|
|
25,031
|
|
Acquisition-related
expense
|
|
|
(19)
|
|
|
|
567
|
|
|
|
573
|
|
|
|
1,162
|
|
Gain (loss) on
contingent consideration
|
|
|
(1,272)
|
|
|
|
—
|
|
|
|
(501)
|
|
|
|
—
|
|
De novo start-up and
other expense
|
|
|
58
|
|
|
|
243
|
|
|
|
1,213
|
|
|
|
5,109
|
|
Recruitment and
retention expense
|
|
|
162
|
|
|
|
—
|
|
|
|
1,467
|
|
|
|
—
|
|
Employee severance
expense
|
|
|
1,235
|
|
|
|
1,662
|
|
|
|
2,889
|
|
|
|
3,447
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
5,435
|
|
Change in accounting
estimate2
|
|
|
—
|
|
|
|
—
|
|
|
|
6,000
|
|
|
|
—
|
|
Facility closure
operating losses and expense
|
|
|
4,343
|
|
|
|
266
|
|
|
|
8,148
|
|
|
|
972
|
|
Adjusted
EBITDA
|
|
$
|
(12,363)
|
|
|
$
|
18,276
|
|
|
$
|
23,681
|
|
|
$
|
67,861
|
|
|
1 Adjusted
EBITDA, adjusted net (loss) income attributable to AAC Holdings,
Inc. common stockholders and adjusted diluted earnings per common
share (herein collectively referred to as "Non-GAAP Disclosures")
are "non-GAAP financial measures" as defined under the rules and
regulations promulgated by the U.S. Securities and Exchange
Commission, each of which are defined below. Management has chosen
to present these Non‐GAAP Disclosures to investors to enable
additional analyses of past, present and future operating
performance and as a supplemental means of evaluating operations
absent the effect of certain items that we do not consider
indicative of our ongoing core operating performance or are
non-cash items. Certain of these items may recur in the future.
Management believes the Non-GAAP Disclosures provide investors with
additional meaningful financial information that should be
considered when assessing our underlying business performance and
trends. We believe the Non-GAAP Disclosures also enhance investors'
ability to compare period-to-period financial results. The
Non-GAAP Disclosures should not be considered as measures of
financial performance under U.S. generally accepted accounting
principles ("GAAP"). The items excluded from the Non-GAAP
Disclosures are significant components in understanding and
assessing our financial performance and should not be considered as
an alternative to net income or other financial statement items
presented in the condensed consolidated financial statements.
Because the Non-GAAP Disclosures are not measures determined in
accordance with GAAP, the Non-GAAP Disclosures may not be
comparable to other similarly titled measures of other
companies.
|
|
Management defines
adjusted EBITDA as net (loss) income attributable to AAC Holdings,
Inc. common stockholders adjusted for interest expense, impairment
of goodwill, depreciation and amortization expense, income tax
benefit, net loss attributable to noncontrolling interest,
stock-based compensation and related tax reimbursements, litigation
settlement, certain regulatory and California matter related
expenses, acquisition-related expense related to the AdCare
acquisition (which includes professional services for accounting,
legal, valuation services and licensing expenses), de novo start-up
and other expenses, recruitment and retention expense, employee
severance expense, change in accounting estimate relating to
partial payments accounts receivable and facility closure operating
losses and expense.
|
|
2
Management has further adjusted for the change in accounting
estimate in order to enhance investors' ability to compare
period-to-period financial results. Although the adjustment
includes revenue from partial payment accounts receivable that the
Company no longer expects to realize based on the change in
estimate, management believes that this adjustment provides
additional meaningful financial information that should be
considered when comparing our financial results for the year ended
December 31, 2018 versus the year ended December 31, 2017 because
our results for the comparable periods in 2017 do not reflect the
refinement of our procedures to more precisely estimate the
collectability of partial payment accounts receivable.
|
AAC HOLDINGS,
INC.
|
|
SUPPLEMENTAL
RECONCILIATION OF NON-GAAP DISCLOSURES
|
|
Unaudited
|
|
(Dollars in
thousands, except share data)
|
|
Reconciliation of
Adjusted Net (Loss) Income Attributable to AAC Holdings, Inc.
Common Stockholders to
Net (Loss) Income Attributable to AAC Holdings, Inc. Common
Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
Years Ended
December 31,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Net (loss) income
attributable to AAC Holdings,
Inc. common stockholders
|
|
$
|
(36,677)
|
|
|
$
|
(16,129)
|
|
|
$
|
(59,404)
|
|
|
$
|
(12,873)
|
|
Non-GAAP
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Litigation settlement,
regulatory and California
matter related expense
|
|
|
8,611
|
|
|
|
24,028
|
|
|
|
15,531
|
|
|
|
25,031
|
|
Acquisition-related
expense
|
|
|
(19)
|
|
|
|
567
|
|
|
|
573
|
|
|
|
1,162
|
|
Gain (loss) on
contingent consideration
|
|
|
(1,272)
|
|
|
|
-
|
|
|
|
(501)
|
|
|
|
-
|
|
De novo start-up and
other expense
|
|
|
58
|
|
|
|
243
|
|
|
|
1,213
|
|
|
|
5,109
|
|
Recruitment and
retention expense
|
|
|
162
|
|
|
|
—
|
|
|
|
1,467
|
|
|
|
—
|
|
Employee severance
expense
|
|
|
1,235
|
|
|
|
1,662
|
|
|
|
2,889
|
|
|
|
3,447
|
|
Loss on extinguishment
of debt
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
5,435
|
|
Change in accounting
estimate
|
|
|
—
|
|
|
|
—
|
|
|
|
6,000
|
|
|
|
—
|
|
Facility closure
operating losses and expense
|
|
|
4,343
|
|
|
|
266
|
|
|
|
8,148
|
|
|
|
972
|
|
Income tax effect of
non-GAAP adjustments
|
|
|
2,835
|
|
|
|
(1,248)
|
|
|
|
(1,522)
|
|
|
|
(1,248)
|
|
Adjusted net (loss)
income attributable to AAC
Holdings, Inc. common stockholders
|
|
$
|
(20,724)
|
|
|
$
|
9,389
|
|
|
$
|
(25,606)
|
|
|
$
|
27,035
|
|
Weighted-average
common shares outstanding -
diluted
|
|
|
24,242,663
|
|
|
|
23,396,502
|
|
|
|
24,090,639
|
|
|
|
23,277,444
|
|
GAAP diluted (loss)
income per common share
|
|
$
|
(1.51)
|
|
|
$
|
(0.80)
|
|
|
$
|
(2.47)
|
|
|
$
|
(0.88)
|
|
Adjusted (loss)
earnings per diluted common
share
|
|
$
|
(0.85)
|
|
|
$
|
0.40
|
|
|
$
|
(1.06)
|
|
|
$
|
1.16
|
|
Management defines adjusted net (loss) income attributable to
AAC Holdings, Inc. common stockholders as net (loss) income
attributable to AAC Holdings, Inc. common stockholders adjusted for
impairment of goodwill, litigation settlement, certain regulatory
and California matter related
expenses, acquisition-related expense (which includes professional
services for accounting, legal, valuation services and licensing
expenses), de novo start-up and other expenses, recruitment and
retention expense, employee severance expense, change in accounting
estimate, facility closure operating losses and expense and the
income tax effect of the non-GAAP adjustments at the then
applicable effective tax rate.
Adjusted diluted earnings per common share represents diluted
earnings per common share calculated using adjusted net income
attributable to AAC Holdings, Inc. common stockholders as opposed
to net income attributable to AAC Holdings, Inc. common
stockholders.
AAC HOLDINGS,
INC.
|
SUPPLEMENTAL
RECONCILIATION OF NON-GAAP DISCLOSURES
|
Unaudited
|
(Dollars in
thousands)
|
|
Reconciliation of
Total Revenues for Adoption of ASC Topic 606
|
|
|
Three Months Ended
December 31, 2017
|
|
|
GAAP
|
|
|
|
|
|
|
Non-GAAP
|
|
|
As
Reported
|
|
|
Adjustment for
Adoption of
ASC Topic 606
|
|
|
Comparable
Basis
|
|
Inpatient treatment
facility services
|
$
|
71,490
|
|
|
$
|
4,668
|
|
|
$
|
66,822
|
|
Outpatient facility
and sober living
services
|
|
9,042
|
|
|
|
388
|
|
|
|
8,654
|
|
Client related
diagnostic services
|
|
3,147
|
|
|
|
2,806
|
|
|
|
341
|
|
Total client related
revenue
|
|
83,679
|
|
|
|
7,862
|
|
|
|
75,817
|
|
Non-client related
revenue
|
|
2,457
|
|
|
|
—
|
|
|
|
2,457
|
|
Total
revenues
|
$
|
86,136
|
|
|
$
|
7,862
|
|
|
$
|
78,274
|
|
|
|
|
|
AAC HOLDINGS,
INC.
|
|
SUPPLEMENTAL
RECONCILIATION OF NON-GAAP DISCLOSURES
|
|
Unaudited
|
|
(Dollars in
thousands)
|
|
|
|
Reconciliation of
Total Revenues for Adoption of ASC Topic 606
|
|
|
|
|
Year Ended
December 31, 2017
|
|
|
GAAP
|
|
|
|
|
|
|
Non-GAAP
|
|
|
As
Reported
|
|
|
Adjustment for
Adoption of
ASC Topic 606
|
|
|
Comparable
Basis
|
|
Inpatient treatment
facility services
|
$
|
246,976
|
|
|
$
|
16,515
|
|
|
$
|
230,461
|
|
Outpatient facility
and sober living
services
|
|
29,080
|
|
|
|
370
|
|
|
|
28,710
|
|
Client related
diagnostic services
|
|
32,482
|
|
|
|
9,047
|
|
|
|
23,435
|
|
Total client related
revenue
|
|
308,538
|
|
|
|
25,932
|
|
|
|
282,606
|
|
Non-client related
revenue
|
|
9,103
|
|
|
|
—
|
|
|
|
9,103
|
|
Total
revenues
|
$
|
317,641
|
|
|
$
|
25,932
|
|
|
$
|
291,709
|
|
|
The tables above
present a reconciliation of total revenues after giving effect to
the adoption of ASC Topic 606 to total revenues, as reported, for
the year ended December 31, 2017. See "Adoption of New Revenue
Recognition Standard" above. Total revenues after giving effect to
the adoption of ASC Topic 606 for the periods presented is a
non-GAAP financial metric. Management has chosen to present this
non-GAAP financial metric as it believes it enhances investors'
ability to compare period-to-period financial results.
|
View original
content:http://www.prnewswire.com/news-releases/aac-holdings-inc-reports-fourth-quarter-and-full-year-2018-results-and-provides-guidance-for-2019-300832568.html
SOURCE AAC Holdings, Inc.